Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We hope to catch up on some reading, hang with one or more of our short people, and take a nap or three. And what about you? This is a fine time to reach out to someone special. You could stimulate the economy with a shopping jaunt. Or you could ready your taxes — remember, the Treasury needs as many as dollars as it can get in order to pay for golf outings taken by a certain someone in the Oval Office. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

The founder of Insys Therapeutics (INSYQ) was sentenced to 5½ years in federal prison for conspiring to bribe doctors to prescribe an addictive opioid painkiller, the Boston Globe says. U.S. District Court Judge Allison Burroughs gave John Kapoor, 76, easily the longest prison sentence of seven defendants convicted in the racketeering case, despite pleas from his lawyer and from Kapoor to show mercy because of his age and accomplishments. Earlier in the day, Alec Burlakoff, a former Insys executive who dressed as a giant fentanyl spray bottle in a rap video that championed the drug, was sentenced to 26 months in prison for participating in the conspiracy. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.